INTRAHEPATIC AND CIRCULANT CD69+ Vδ1 T-CELLS PREDICT SURVIVAL IN PATIENTS UNDERGOING HEPATECTOMY FOR COLORECTAL LIVER METASTASES

被引:0
|
作者
Donadon, Matteo
Costa, Guido
Cimino, Matteo
Soldani, Cristiana
Franceschini, Barbara
Mikulak, Joanna
Mavilio, Domenico
Torzilli, Guido
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
40
引用
收藏
页码:S1299 / S1299
页数:1
相关论文
共 44 条
  • [1] CD69+ Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma
    You, Hongqin
    Wang, Yixin
    Wang, Xiaokun
    Zhu, Huifang
    Zhao, Yajie
    Qin, Peng
    Liu, Xue
    Zhang, Mengyu
    Fu, Xiaomin
    Xu, Benling
    Zhang, Yong
    Wang, Zibing
    Gao, Quanli
    MOLECULAR IMMUNOLOGY, 2024, 172 : 76 - 84
  • [2] RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases
    Denbo, Jason W.
    Yamashita, Suguru
    Passot, Guillaume
    Egger, Michael
    Chun, Yun S.
    Kopetz, Scott E.
    Maru, Dipen
    Brudvik, Kristoffer Watten
    Wei, Steven H.
    Conrad, Claudius
    Vauthey, Jean-Nicolas
    Aloia, Thomas A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (01) : 68 - 77
  • [3] RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases
    Jason W. Denbo
    Suguru Yamashita
    Guillaume Passot
    Michael Egger
    Yun S. Chun
    Scott E. Kopetz
    Dipen Maru
    Kristoffer Watten Brudvik
    Steven H. Wei
    Claudius Conrad
    Jean-Nicolas Vauthey
    Thomas A. Aloia
    Journal of Gastrointestinal Surgery, 2017, 21 : 68 - 77
  • [4] RAS Mutation Status Impacts Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases
    Denbo, Jason
    Passot, Guillaume
    Chun, Yun Shin
    Yamashita, Suguru
    Kopetz, Scott
    Maru, Dipen
    Brudvik, Kristoffer W.
    Wei, Steven
    Conrad, Claudius
    Aloia, Thomas
    Vauthey, Jean-Nicolas
    GASTROENTEROLOGY, 2016, 150 (04) : S1174 - S1174
  • [5] Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated αβ T-cells
    Ishii, Fuminori
    Yoshida, Yoichiro
    Yamauchi, Yasushi
    Aisu, Naoya
    Kojima, Daibo
    Mera, Toshiyuki
    Kato, Daisuke
    Tanaka, Toshihiro
    Naito, Keiko
    Yasumoto, Kosei
    Kamigaki, Takashi
    Goto, Shigenori
    Hamada, Yoshihiro
    Nimura, Satoshi
    Kodama, Shohta
    Hasegawa, Suguru
    ANTICANCER RESEARCH, 2017, 37 (07) : 3933 - 3939
  • [6] RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
    Vauthey, Jean-Nicolas
    Zimmitti, Giuseppe
    Kopetz, Scott E.
    Shindoh, Junichi
    Chen, Su S.
    Andreou, Andreas
    Curley, Steven A.
    Aloia, Thomas A.
    Maru, Dipen M.
    ANNALS OF SURGERY, 2013, 258 (04) : 619 - 627
  • [7] Composite Score: prognostic tool to predict survival in patients undergoing surgery for colorectal liver metastases
    Fruhling, Petter
    Urdzik, Jozef
    Stromberg, Cecilia
    Isaksson, Bengt
    BJS OPEN, 2021, 5 (05):
  • [8] Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases
    Korita, Pavel V.
    Wakai, Toshifumi
    Shirai, Yoshio
    Sakata, Jun
    Takizawa, Kazuyasu
    Cruz, Pauldion V.
    Ajioka, Yoichi
    Hatakeyama, Katsuyoshi
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) : 3472 - 3480
  • [9] Intrahepatic Lymphatic Invasion Independently Predicts Poor Survival and recurrences after Hepatectomy in Patients with Colorectal Carcinoma Liver Metastases
    Daniel Jaeck
    Elie Oussoultzoglou
    Annals of Surgical Oncology, 2007, 14 : 3297 - 3298
  • [10] Intrahepatic Lymphatic Invasion Independently Predicts Poor Survival and Recurrences after Hepatectomy in Patients with Colorectal Carcinoma Liver Metastases
    Pavel V. Korita
    Toshifumi Wakai
    Yoshio Shirai
    Jun Sakata
    Kazuyasu Takizawa
    Pauldion V. Cruz
    Yoichi Ajioka
    Katsuyoshi Hatakeyama
    Annals of Surgical Oncology, 2007, 14 : 3472 - 3480